Schedule 13G ownership disclosure
Cumberland Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 230770109
Event date: 2016-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000936753-16-000311
- Form type
- SC 13G
- Filer
- ARIEL INVESTMENTS, LLC
- CIK
- CIK 936753
- Filed
- Apr 08, 2016
- Reporting period
- Mar 31, 2016
- Description
- Schedule 13G beneficial ownership